コーポレート

Greenberg Traurig's Corporate Practice focuses on the business objectives of our clients. More than 600 corporate and securities lawyers work together to provide clients with the legal and market experience needed to manage and close the most complex transactions, as well as provide practical counsel on clients' day-to-day operations.

We advise public and privately held companies on mergers and acquisitions, corporate restructurings, private equity and venture capital, underwritten and syndicated offerings, commercial finance and syndicated lending, cross-border transactions and general corporate matters. Our industry experience includes transactions in a wide range of fields, from the pharmaceutical, medical devices and life sciences fields, to representations involving clients in the aviation, banking, energy, health care, manufacturing, technology, and telecommunications sectors.

We offer corporate clients the combined benefits of local presence and global resources, providing advice and services to companies and entrepreneurs throughout the Americas, Europe, Asia, and the Middle East.

Corporate Transparency Act Task Force

On Jan. 1, 2024, the Corporate Transparency Act (CTA) took effect, requiring non-exempt U.S. entities and non-exempt foreign entities registered to do business in the United States to submit beneficial ownership information (BOI) reports to a confidential database maintained by the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN). Learn more about Greenberg Traurig’s Corporate Transparency Act Task Force.

Contact Us

To learn more about our Corporate capabilities, please feel free to reach out to our Corporate Practice contacts.